Featured Announcements

1. $China Merchants Bank (03968.HK)$ : Appoint Wang Liang as President

China Merchants Bank (03968) announced that the board of directors held the 40th meeting of the 11th board of directors on May 19, 2022, at which it reviewed and approved the “Proposal on the Appointment of Mr. Wang Liang as President of China Merchants Bank”, agreeing to appoint Wang Liangwei The president of China Merchants Bank, whose term of office starts from the date when the China Banking and Insurance Regulatory Commission approves his qualification for the office of president, ends on the date when the eleventh session of the board of directors expires.

2. $Xiaomi Group-W (01810.HK)$ Q1 revenue of 73.352 billion yuan, down 4.6% year-on-year

Xiaomi Group (01810) released its 2022 Q1 performance report: Q1 revenue was 73.352 billion yuan (RMB, the same below), down 4.6% year-on-year; Q1 adjusted net profit was 2.859 billion yuan, down 52.9% year-on-year; Q1 gross profit was 12.710 billion yuan, a year-on-year decrease of 10.2%. By business: Q1 smartphone revenue was 45.763 billion yuan; IoT and consumer products revenue was 19.477 billion yuan; Internet service revenue was 7.113 billion yuan.

3. $Zhaoke Ophthalmology-B(06622.HK)$ : The first patient enrolled in the Phase III bridging clinical trial of NVK002 (small CHAMP) in China

Zhaoke Ophthalmology-B (06622) announced that the first patient of the one-year Phase III bridging clinical trial (“small CHAMP”) of NVK002, one of the company’s core products, has been enrolled on May 13, 2022. Earlier in March 2022, the company announced the enrollment of the first patient in a concurrent two-year Phase III clinical trial (“CHAMP China”), and as of May 16, 2022, CHAMP China has successfully enrolled 144 patients Patients, recruitment is still in progress.

4. $Zhengtong Auto (01728.HK)$ : SAIC Motor won the 1.52 billion unlisted foreign shares of Dongzheng Finance held by the company for 1.607 billion yuan, and resumed trading today

Zhengtong Automobile (01728) announced that according to the relevant auction details page of the JD.com judicial auction online platform, the equity auction has ended at 10:00 a.m. on May 19, 2022. SAIC Motor Corporation Limited (the “Buyer”) successfully auctioned 1.52 billion unlisted foreign shares of Dongzheng Finance held by the company at a transaction price of RMB 1.607 billion.

5. $Smore International (06969.HK)$ granted a total of 11.975 million share options

Smol International (06969) announced that on May 19, 2022, the company granted a total of 11.975 million share options to certain qualified employees of the group according to the post-IPO share option plan adopted on June 15, 2020. The number of share options granted was 11.975 million share options in total, and the closing price of the shares on the date of grant was HK$16.80 per share.

6. $Baixinan-B(02185.HK)$ : Carry out the RADIUS-HTN test in EUROPCR

Biosafety-B (02185) announced that at EuroPCR 2022 (the official annual meeting of the European Association for Percutaneous Cardiovascular Interventional Therapy), the company and clinical trial investigators finalized plans involving renal artery sympathetic denervation using the radial artery approach. European Clinical Trial in Hypertension (RADIUS-HTN) (“RADIUS-HTN Trial”). The European Centre for Cardiovascular Research (“CERC”) will conduct the RADIUS-HTN trial and evaluate the company’s second-generation Iberis® renal nerve block (RDN) system in patients with uncontrolled hypertension. The RADIUS-HTN trial will compare the efficacy of renal nerve block via a transradial approach (TRA) and a transarterial approach (TFA). The Principal Investigator of the RADIUS-HTN trial is Prof. Felix Mahfoud, MD from Saarland University Hospital, Homburg/Saar, and Chairman of the Working Group on Arterial Hypertension of the German Society of Cardiology.

7. $Weichai Power (02338.HK)$ plans to repurchase A shares not exceeding 1.533 billion yuan, and the price should not exceed 17.57 yuan per share

Weichai Power (02338) announced that the company plans to use its own funds to repurchase some of the company’s A-share public shares for the later implementation of the equity incentive plan. ), the number of A shares repurchased is expected to be no less than 0.5% of the company’s total share capital and no more than 1% of the total share capital, that is, no less than 43,632,784 shares (inclusive) and no more than 87,265,568 shares (inclusive). Based on the upper limit of the repurchase quantity of 87,265,568 shares (inclusive) and the repurchase price upper limit of 17.57 yuan per share (inclusive), it is estimated that the total repurchase funds will not exceed RMB 1.533 billion.

8. $Ximei Resources (09936.HK)$ plans to allocate 60 million new shares to Ganfeng Lithium

Ximei Resources (09936) announced that on May 19, 2022, the Company, the Subscriber (an indirect wholly-owned subsidiary of Ganfeng Lithium) and China Galaxy entered into a Framework Subscription Agreement, pursuant to which the Subscriber intends to subscribe and the Company intends to subscribe. 60 million new shares were allotted and issued at the proposed subscription price of HK$4.0 per proposed subscription share.

Major issues

CanSinoBio-B(06185): Kwesa is included in the WHO Emergency Use List

Fosun Pharma USA, a holding subsidiary of Fosun Pharma (02196), has been granted the exclusive license by VerImmune to develop, import and commercialize the tumor immunotherapy drug VERI-101 in China

Lee’s Pharmaceutical Factory (00950): NATULAN obtained the drug registration license

Henlius (02696): An international multi-center Phase 3 clinical study of Hansezoid® (Slulimumab injection) combined with chemotherapy and radiotherapy for the treatment of limited-stage small cell lung cancer has completed the first patient administration in China

Fosun Pharma (02196): Holding Subsidiary Signs License Agreement for Immuno-Oncology Drug VERI-101

financial data

Xiaomi Group-W (01810): Q1 revenue was 73.352 billion yuan, down 4.6% year-on-year

Tongcheng Travel (00780): Adjusted EBITDA in the first quarter increased by 4.4% year-on-year to 438 million yuan

Parkson Group (03368): Loss attributable to owners of the company was 30.1 million yuan in the first quarter

GDS-SW (09698) net income in the first quarter was 2.243 billion yuan, a year-on-year increase of 31.5%

Increase or decrease holdings

Innocent City Technology (09911) gained 100,000 shares by Chairman Liu Chunhe

M&A sale

Fantasia Holdings (01777) plans to sell the residential property development project in Yuecheng District, Shaoxing, Zhejiang for 760 million yuan

Centurion Enterprises (06090) to acquire properties surrounding Nottingham City University for HK$102 million

Jingdong Logistics (02618) subsidiary plans to sell 100% equity of Jingdong International Financial Leasing for US$30 million

COSCO SHIPPING Development (02866) plans to transfer 10% equity of COSCO SHIPPING Group Finance Company for 910 million yuan and increase its capital by about 1.807 billion yuan

COSCO SHIPPING Holdings (01919) plans to acquire the equity of COSCO SHIPPING Group Finance, and the registered capital of COSCO SHIPPING Group Finance will increase to 19.5 billion yuan

investment operation

Goldwind Technology (02208) plans to apply for filing and listing a debt financing plan of no more than 500 million yuan at the Beijing Gold Exchange

National Joint Resources (00254) is working on exploring and developing the freight and logistics industry

repurchase cancellation

AIA (01299) repurchased 2.1 million shares at a cost of HK$162 million on May 19

Jingdong Health (06618) spent HK$30.375 million to repurchase 655,700 shares on May 19

SMIC (00981) repurchased 4.215 million shares at HK$66.566 million on May 19

Tigermed (03347) spent RMB 29.5815 million to repurchase 349,400 A shares on May 19

Sinotrans (00598) spent 10.2254 million yuan to repurchase 2.6947 million A shares on May 19

ESR (01821) repurchased 963,000 shares at a cost of HK$21.56 million on May 19

Haier Smart Home (06690) spent 82.93 million yuan to repurchase 3.29 million A shares on May 19

Cogobuy (00400) repurchased 1.2 million shares at a cost of HK$2.604 million on May 19

HSBC Holdings (00005) repurchased 1.46 million shares at a cost of £7.26 million on May 18

Standard Chartered Group (02888) repurchased 1,182,300 shares at a cost of £6,999,600 on May 18

Guotai Junan International (01788) repurchased 2.583 million shares at a cost of HK$2.1865 million on May 19

Equity incentive

China Life Group (08296) granted a total of 26 million share options

Sino Biopharmaceutical (01177): The trustee purchased a further 9 million shares

Li Ning (02331) issued 300,000 shares under the share option plan

Additional rights issue

Fullshare Holdings (00607) plans to place no more than 2.956 billion shares at a discount of 8.26%, raising a maximum of HK$296 million

bond notes

Yuexiu Properties (00123): Guangzhou Urban Construction plans to issue no more than 2.15 billion corporate bonds

Longfor Group (00960): Subsidiary issue of corporate bonds not exceeding 500 million yuan

Jingdong Logistics (02618): sold 100% equity of Jingdong International Financial Leasing to Jingdong Technology for 203 million yuan

This article is reprinted from: https://news.futunn.com/post/15715221?src=3&report_type=market&report_id=206157&futusource=news_headline_list
This site is for inclusion only, and the copyright belongs to the original author.